Eligibility Survey
Kadima Neuropsychiatry Institute is seeking participants for a clinical study of the
investigational drug MM120 (a pharmaceutical formulation of LSD) for Major Depressive Disorder (MDD).
The sponsor of this study is Mind Medicine Inc. The principal investigator at our site is David Feifel, MD, Ph.D. This study is taking place at Kadima's location in La Jolla, CA.
The following survey will assess your current eligibility to participate in this trial. This survey should take approximately 3 minutes to complete.
Please answer as honestly and as completely as possible. Responses will be verified at the next stage through your medical records and/or in-person assessments.
You can find more information about this study here.
This survey platform is HIPAA-compliant and designed to protect your protected health information (PHI).
Information entered will only be used for the purposes of eligibility assessment by KADIMA Research Staff members.